The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children
NCT ID: NCT02064660
Last Updated: 2015-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
20 participants
INTERVENTIONAL
2013-12-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aimed to assess the overall effectiveness, safety of periocular acupressure for children with myopia
The hypotheses of this study are as follows:
Periocular acupressure is effective for myopia progression delay.
The study aims to include 56 participants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eye Exercise, Transcutaneous Electrical Nerve Stimulation on Prevention of Myopia Progression
NCT04017234
Pilot Study of Accommodative/Vergence Therapy to Modify Accommodative Function in Children With Myopia
NCT02578407
Auricular Acupressure Reduces Rebound Effects After Discontinuation of Atropine
NCT07129889
Effect of Vision Therapy in Myopic Children With Poor Accommodative Response
NCT03006601
the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control
NCT02055378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single arm
A series of acupressure sessions within six months from the baseline
massager
The patients will be doing self-stimulation using acupressure device, The acupuncture treatment will be applied two times per day for six months. Acupressure divice will stimulate for 14 minutes. Examples of acupuncture points to be used might include GB1, GB14, TE23, ST1, ST2, BL01, BL02, the Extra-point Tae-yang, In-dang.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
massager
The patients will be doing self-stimulation using acupressure device, The acupuncture treatment will be applied two times per day for six months. Acupressure divice will stimulate for 14 minutes. Examples of acupuncture points to be used might include GB1, GB14, TE23, ST1, ST2, BL01, BL02, the Extra-point Tae-yang, In-dang.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spherical equivalent greater than -5D
* Individuals without strabismus, anistopia
* Willingness to participate in the study
Exclusion Criteria
* Individuals who were received ocular or scalp trauma.
* Individuals who were received ocular surgery and had ocular wound.
* Individuals who were adapted bifocal lense.
* Individuals suffering fever or bad conditions.
* Individuals suffering systemic or neurologic disease.
* Indibiduals who were receiving other therapy during the period of study
* Individuals who did not comply with the treatment which affected myopia progression.
7 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea Institute of Oriental Medicine
OTHER_GOV
Korean Medicine Hospital of Pusan National University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ki-Bong, Kim
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ki-bong Kim
Role: PRINCIPAL_INVESTIGATOR
Pusan National University Korean Medicine Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pusan National University Korean Medicine Hospital
Yangsan, Gyeongsangnam-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
blueicek
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.